4Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Ann Rev Biochem, 2003, 72:137-174.
5Paumgartner G, Beuers U. Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. Clin Liver Dis,2004, 8:67-81.
6Lutjohann D, Hahn C, Prange W, et al. Influence of rifampin on serum markers of cholesterol and bile acid synthesis in men. Int J Clin Pharmacol Ther, 2004,42: 307-313.
7Kullak-Ublick GA, Stieger B, Meier PJ. Enterohepatic bile salt transporters innormal physiology and liver disease. Gastroenterology,2004, 126:322-342.
8Vilca Melendez H, Rela M, Setchell KD, et al. Bile acids analysis: a tool to assess graft function in human liver transplantation. Transpl Int, 2004, 17:286-292.
9Bore KE, Heubi JE, Balistreri WF, et al. Bile Acid synthetic defects and liver disease: a comprehensive review. Pediatr Der Pathol, 2004,7:315-334.
10Anwer MS. Cellular regulation of hepatic bile acid transport in health and cholestasis. Hepatology, 2004, 39:581-190.
2Suzanne Logan, MS, RD. The use of prealbumin to enhance nutrition intervention screening and monitoring of the malnourished patient [ J ]. Gstroenterology, 2005 ( 123 ) : 585 - 5961.
